Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Gross Profit (2020 - 2025)

Historic Gross Profit for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $179.8 million.

  • Harmony Biosciences Holdings' Gross Profit rose 2550.96% to $179.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $641.7 million, marking a year-over-year increase of 1965.56%. This contributed to the annual value of $557.9 million for FY2024, which is 2107.99% up from last year.
  • Harmony Biosciences Holdings' Gross Profit amounted to $179.8 million in Q3 2025, which was up 2550.96% from $162.3 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Gross Profit's 5-year high stood at $179.8 million during Q3 2025, with a 5-year trough of $49.3 million in Q1 2021.
  • Its 5-year average for Gross Profit is $111.5 million, with a median of $109.2 million in 2023.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Gross Profit skyrocketed by 20102.04% in 2021 and then surged by 1194.64% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Gross Profit (Quarter) stood at $73.4 million in 2021, then surged by 38.19% to $101.4 million in 2022, then grew by 23.5% to $125.3 million in 2023, then increased by 17.24% to $146.9 million in 2024, then grew by 22.43% to $179.8 million in 2025.
  • Its Gross Profit stands at $179.8 million for Q3 2025, versus $162.3 million for Q2 2025 and $152.7 million for Q1 2025.